Silymarin efficacy against influenza A virus replication. : Terry Talks Nutrition

Study Spotlight

Study Spotlight

Silymarin efficacy against influenza A virus replication.

The anti-influenza A/PR/8/34 virus activity of silymarin was evaluated in MDCK cells and investigated the effect of silymarin on synthesis of viral mRNAs. Silymarin was investigated for its antiviral activity against influenza A/PR virus using a cytopathic effect (CPE) reduction method. Silymarin exhibited anti-influenza A/PR/8/34 virus activity of 98% with no cytotoxicity at the concentration of 100μg/ml reducing the formation of a visible CPE. Oseltamivir also did show moderate antiviral activity of about 52% against influenza A/PR/8/34 virus at the concentration of 100μg/ml. Furthermore, the mechanism of anti-influenza virus action in the inhibition of viral mRNA synthesis was analyzed by Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR), and the data indicated an inhibitory effect in late viral RNA synthesis compared with oseltamivir in the presence of 100μg/ml of silymarin. Therefore, the potential of silymarin for use in treating influenza virus infection merits greater attention.

Click Here to visit the journal website. Subscription required to view the full text of the article.

Our website uses cookies to track website usage and preferences. You can read more about cookies here or by visiting our privacy policy. I Understand
Website by Webfitters